FPRX · Five Prime Therapeutics Inc
Acquired Company
Amgen acquired Five Prime Therapeutics for $38.00 per share in cash, with an equity value of approximately $1.9 billion, and the transaction closed on April 16, 2021.
111 Oyster Point Blvd, California, 94080-1910, US
Pharmaceutical Preparation Manufacturing
Manufacturing
Market Cap
N/A
52 Wk Range
N/A - N/A
Previous Close
$38.00
Open
$38.00
Volume
N/A
Day Range
$38.00 - $38.00
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
N/A
Institutional Own.
N/A
Qtr Updated
Jun 30th 2024